Literature DB >> 20088757

TSG101: a novel anti-HIV-1 drug target.

Hongfei Chen1, Xinyong Liu, Zhenyu Li, Peng Zhan, Erik De Clercq.   

Abstract

The life cycle of HIV-1 requires extensive assistance from the host cell proteins and pathways. TSG101 is one of the cellular proteins involved in the budding process of HIV-1, and plays an important role in the cellular vacuolar protein sorting (Vps) pathway. Its main function being recognizing ubiquitinated cargo, TSG101 also proved to be essential for the budding process of HIV-1 virions. In this process, TSG101 is recruited from internal site of the infected cell to the budding site to aid in the release of the HIV-1 virus particles. Depletion of TSG101 from virus-producing cells can lead to a budding defect. Therefore, TSG101 is a potentially new attractive target for therapeutic intervention in AIDS. This review describes the structure and function of TSG101 and latest progress in the discovery of TSG101-directed HIV-1 inhibitors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20088757     DOI: 10.2174/092986710790514444

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  17 in total

1.  Viral and host proteins that modulate filovirus budding.

Authors:  Yuliang Liu; Ronald N Harty
Journal:  Future Virol       Date:  2010-07-01       Impact factor: 1.831

2.  Oxime-based linker libraries as a general approach for the rapid generation and screening of multidentate inhibitors.

Authors:  Medhanit Bahta; Fa Liu; Sung-Eun Kim; Andrew G Stephen; Robert J Fisher; Terrence R Burke
Journal:  Nat Protoc       Date:  2012-03-15       Impact factor: 13.491

3.  Small-molecule probes targeting the viral PPxY-host Nedd4 interface block egress of a broad range of RNA viruses.

Authors:  Ziying Han; Jianhong Lu; Yuliang Liu; Benjamin Davis; Michael S Lee; Mark A Olson; Gordon Ruthel; Bruce D Freedman; Matthias J Schnell; Jay E Wrobel; Allen B Reitz; Ronald N Harty
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

4.  Elucidation of New Binding Interactions with the Tumor Susceptibility Gene 101 (Tsg101) Protein Using Modified HIV-1 Gag-p6 Derived Peptide Ligands.

Authors:  Sung-Eun Kim; Fa Liu; Young Jun Im; Andrew G Stephen; Matthew J Fivash; Abdul A Waheed; Eric O Freed; Robert J Fisher; James H Hurley; Terrence R Burke
Journal:  ACS Med Chem Lett       Date:  2011-05-12       Impact factor: 4.345

5.  A host-oriented inhibitor of Junin Argentine hemorrhagic fever virus egress.

Authors:  Jianhong Lu; Ziying Han; Yuliang Liu; Wenbo Liu; Michael S Lee; Mark A Olson; Gordon Ruthel; Bruce D Freedman; Ronald N Harty
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

6.  Quinoxaline-based inhibitors of Ebola and Marburg VP40 egress.

Authors:  H Marie Loughran; Ziying Han; Jay E Wrobel; Sarah E Decker; Gordon Ruthel; Bruce D Freedman; Ronald N Harty; Allen B Reitz
Journal:  Bioorg Med Chem Lett       Date:  2016-06-23       Impact factor: 2.823

7.  A novel cell-based high-throughput screen for inhibitors of HIV-1 gene expression and budding identifies the cardiac glycosides.

Authors:  Gregory M Laird; Evelyn E Eisele; S Alireza Rabi; Daria Nikolaeva; Robert F Siliciano
Journal:  J Antimicrob Chemother       Date:  2013-11-24       Impact factor: 5.790

8.  Replication-competent recombinant porcine reproductive and respiratory syndrome (PRRS) viruses expressing indicator proteins and antiviral cytokines.

Authors:  Yongming Sang; Jishu Shi; Wenjing Sang; Raymond R R Rowland; Frank Blecha
Journal:  Viruses       Date:  2012-01-18       Impact factor: 5.048

9.  Zika Virus Hijacks Extracellular Vesicle Tetraspanin Pathways for Cell-to-Cell Transmission.

Authors:  Sara B York; Li Sun; Allaura S Cone; Leanne C Duke; Mujeeb R Cheerathodi; David G Meckes
Journal:  mSphere       Date:  2021-06-30       Impact factor: 4.389

10.  Identifying chemicals with potential therapy of HIV based on protein-protein and protein-chemical interaction network.

Authors:  Bi-Qing Li; Bing Niu; Lei Chen; Ze-Jun Wei; Tao Huang; Min Jiang; Jing Lu; Ming-Yue Zheng; Xiang-Yin Kong; Yu-Dong Cai
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.